OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction
The key roles of Major Histocompatibility Complex (MHC) Class I and II molecules in the immune system are well established. This study aims to develop a novel machine learning framework for predicting antigen peptide presentation by MHC Class I and II molecules. By integrating large-scale mass spect...
Saved in:
| Main Authors: | Fangfang Jian, Haihua Cai, Qushuo Chen, Xiaoyong Pan, Weiwei Feng, Ye Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1550252/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generalization of neoantigen-based tumor vaccine by delivering peptide-MHC complex via oncolytic virus
by: Chenyi Wang, et al.
Published: (2025-04-01) -
MHC-I pathway disruption by viruses: insights into immune evasion and vaccine design for animals
by: Yanan Wu, et al.
Published: (2025-05-01) -
Preparation of peptide–MHC and T-cell receptor dextramers by biotinylated dextran doping
by: Michael T. Bethune, et al.
Published: (2017-03-01) -
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
by: Ali Afzal, et al.
Published: (2025-01-01) -
Study on the contrast of the MHC–peptide interaction of B2/B21 haplotype and MHC‐related virus resistance in chickens
by: Yuan‐chang Jin, et al.
Published: (2021-12-01)